Skip to main content

Lichen International Ltd

corporate_fare Company Profile

Lichen International Ltd

LICN·NASDAQ·Industrials·CIK 0001876766

Lichen International Limited is a holding company that controls and receives economic benefits from its subsidiaries' business operations, primarily through equity ownership in its PRC subsidiaries. The company was incorporated on April 13, 2016, in the Cayman Islands. As of the date of this annual report, its authorized share capital is US$200,000,000, divided into 20,000,000,000 Class A Ordinary Shares and 5,000,000,000 Class B Ordinary Shares. Of these, 16,326,825 Class A Ordinary Shares and 110,000 Class B Ordinary Shares are issued and outstanding. The company's main operating entity is Lichen Zixun, established on April 14, 2004, under the laws of the PRC, and is a wholly owned subsidiary of Legend Consulting HK. Legend Consulting HK was formed on January 8, 2014, in Hong Kong, and is a wholly owned subsidiary of Legend Consulting BVI. Legend Consulting BVI, incorporated on December 20, 2013, in the British Virgin Islands, is a wholly owned subsidiary of Lichen International Limited. Other subsidiaries include Lichen Singapore, established on December 28, 2023, in Singapore, and Bondly HK, established on June 13, 2022, in Hong Kong. Bondly XM was established on August 25, 2022, in the PRC, and is a wholly owned subsidiary of Bondly HK. Lichen Yingtan is an investment holding company wholly owned by Legend Consulting HK. Legend Technology, wholly owned and established by Lichen Zixun on July 9, 2025, provides technology promotion and application services.

Lichen International Ltd (NASDAQ:LICN) is a publicly traded company in the Industrials sector. Wiseek monitors LICN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Lichen International Reports Steep Losses, Going Concern Doubt, and Massive Dilution Amid Nasdaq Compliance Efforts
  • Lichen International Shareholders Approve Massive Share Capital Increase, Reverse Split, and Optional Annual Meetings

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$809K
Net Income
-$21.96M
Diluted EPS
-$4.11
Op. Cash Flow
-$17.85M
Free Cash Flow
-$17.85M
Gross Profit
$9.14M
Operating Income
-$18.07M
Cash & Equivalents
$26.91M
Debt / Equity
0.00×
Net Margin
-27.15×
Shares Outstanding
5.3M sh
Source: 20-F · filed 2026-04-28 · accession 0001185185-26-001520

Insider Transactions

LICN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with L →
$2.82
52-week range · as of 2026-04-28 $2.57 – $8.28
Market cap
$46.35M
Volume
530.9K (1.0× avg)
3-mo avg 557.9K
Live data · 2026-06-14 03:53 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LICN - Latest Insights

LICN
Apr 28, 2026, 4:31 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $4.00
Real-time Price: $2.82 info
Change: -$1.18 (-30%) info
Market Cap: $46.352M info
LICN
Jan 07, 2026, 5:00 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.13
Real-time Price: $2.82 info
Change: -$0.310 (-10%) info
Market Cap: $46.352M info